Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: Continuous glucose monitoring (CGM) has potential to address challenges of type 1 diabetes (T1D) management for young children. CGM use is increasing, yet remains underutilized. Characterizing parents' experiences with CGM can inform clinical strategies to help parents make decisions about diabetes management, overcome obstacles to initiating and sustaining CGM use, and maximize benefits of CGM use in their children's diabetes care. Methods: Transcripts from semistructured qualitative interviews with 55 parents of children aged 1 to <8 years, with T1D duration ≥6 months, and whose child currently or previously used CGM were coded and analyzed to derive themes about their experiences with CGM. Results: Participants were 88% mothers and the mean child age was 5.0 ± 1.5 years. Parents described benefits of CGM use: decreased worry about glucose excursions, improved sleep, increased sense of safety with children who cannot recognize or express symptoms of hypo- or hyperglycemia, and greater comfort with other caregivers, especially using remote monitoring functionality when away from children. Challenges included painful insertions, wearing multiple devices on small bodies, disruptive alerts, data gaps due to lost signals, skin/adhesive problems, and difficulty interpreting the amount of information generated by CGM. For some, the challenges outweighed potential benefits and they stopped CGM use. Conclusions: CGM may address unique challenges of T1D in young children and increase parental comfort with diabetes management, yet there are multiple barriers to initiating or maintaining CGM use. Education and behavioral support to address these benefits and barriers may equip caregivers with skills to address challenges of CGM use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes
Bergenstal, R. M., Garg, S., Weinzimer, S. A., Buckingham, B. A., Bode, B. W., Tamborlane, W. V., & Kaufman, F. R. (2016) · JAMA · doi:10.1001/jama.2016.11708 · Cited by 644 · cited 1×
“For example, consistent use of CGM sensors is a central component of hybrid closed-loop insulin delivery systems that regulate between meal and overnight insulin infusion rates automatically.(22) The parents in this study endorsed benefits, including increased sense of security and having fewer diabetes care tasks to…”
BackgroundSelf-citationContinuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes
Rodbard, D. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0035 · Cited by 458
DeSalvo, D. J., Miller, K. M., Hermann, J. M., Maahs, D. M., Hofer, S. E., Clements, M. A., Lilienthal, E., Sherr, J. L., Tauschmann, M., Holl, R. W., et al. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12711 · Cited by 233 · cited 1×
“Similar increases have been reported in other countries.(10) Consequently, this study was undertaken to obtain a better understanding of the current experiences using CGM by parents of young children with T1D, and to inform the development of a behavioral intervention for families of young children with T1D initiating…”
ResultSelf-citationMauras, N., Beck, R., Xing, D., Ruedy, K., Buckingham, B., Tansey, M., White, N. H., Weinzimer, S. A., Tamborlane, W., Kollman, C., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1746 · Cited by 204
Self-citationVan Name, M. A., Hilliard, M. E., Boyle, C. T., Miller, K. M., DeSalvo, D. J., Anderson, B. J., Laffel, L. M., Woerner, S. E., DiMeglio, L. A., & Tamborlane, W. V. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12525 · Cited by 139
Self-citationStress among fathers of young children with type 1 diabetes
Mitchell, S. J., Hilliard, M. E., Mednick, L., Henderson, C., Cogen, F. R., & Streisand, R. (2009) · Families, Systems, & Health · doi:10.1037/a0018191 · Cited by 94
Self-citationDiabetes Research in Children Network (DirecNet) Study Group (2009) · Diabetes Care · doi:10.2337/dc08-2298 · Cited by 61
Cited by
7. Diabetes Technology: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s007 · Cited by 202
Strategies to Enhance New CGM Use in Early Childhood (SENCE) Study Group, Laffel, L., Harrington, K., Hanono, A., Naik, N., Ambler-Osborn, L., Schultz, A., DiMeglio, L., Woerne, S., Jolivette, H., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1060 · Cited by 95
Self-citationMerino, J., Linenberg, I., Bermingham, K. M., Ganesh, S., Bakker, E., Delahanty, L. M., Chan, A. T., Capdevila Pujol, J., Wolf, J., Al Khatib, H., et al. (2022) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac026 · Cited by 46
Benefits and limitations of continuous glucose monitoring in type 1 diabetes
Stone, J. Y., & Bailey, T. S. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1706482 · Cited by 30
“emotional burden of having diabetes in general can be exacerbated by CGM use in that it serves as a constant reminder of their diabetes, the continuous stream of glucose information can be overwhelming, and the device causes their disease to be ‘visible’, emphasizing that they are different from others [40,44].”
BackgroundInfluentialUse of Diabetes Technology in Children
Desrochers, H. R., Schultz, A. T., & Laffel, L. M. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.11.001 · Cited by 29
Self-citation
Metadata
- Authors
- Hilliard, M. E., Levy, W., Anderson, B. J., Whitehouse, A. L., Commissariat, P. V., Harrington, K. R., Laffel, L. M., Miller, K. M., Van Name, M., Tamborlane, W. V., DeSalvo, D. J., & DiMeglio, L. A.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2019-09-01
- Volume
- 21
- Issue
- 9
- Pages
- 493-498
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2961898176
- Cited by
- 134
- References
- 7
- FWCI
- 11.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.